ASCO 2019: Phase III Trial Establishes Hippocampal Avoidance Strategy as Gold Standard in Whole Brain Radiation Therapy With Memantine
It also provides the first definitive clinical evidence of cognition-specific radiation sensitivity of hippocampal neurogenesis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.